Hawkins Reports Strong Fiscal 2026 Revenue & Cash Flow Growth, Driven by Strategic Acquisitions
summarizeSummary
Hawkins Inc. reported strong fiscal 2026 revenue and cash flow growth, driven by significant strategic acquisitions, despite a slight dip in reported diluted EPS.
check_boxKey Events
-
Strong Fiscal 2026 Financial Performance
Sales increased 11% to $1.08 billion, and operating cash flow grew 30% to $144.3 million. Diluted EPS decreased 3% to $3.91, but pro forma diluted EPS increased 9% to $3.95.
-
Significant Strategic Acquisitions
The company completed six acquisitions in fiscal 2026 for a total cash consideration of $167.1 million, including the $149.9 million acquisition of WaterSurplus, which significantly expanded the Water Treatment segment.
-
Increased Debt to Fund Growth
Long-term debt rose to $244 million from $149 million in the prior year, primarily to finance the acquisitions, leading to an increase in interest expense.
-
Segment Realignment
Effective in the first quarter of fiscal 2026, Hawkins realigned its reporting segments to Water Treatment, Food and Health Sciences, and Industrial Solutions to better reflect its business strategy.
auto_awesomeAnalysis
Hawkins Inc.'s annual report reveals solid financial performance for fiscal 2026, with an 11% increase in sales to $1.08 billion and a 30% surge in operating cash flow to $144.3 million. This growth was significantly bolstered by six strategic acquisitions totaling $167.1 million, including the $149.9 million purchase of WaterSurplus, which expanded the Water Treatment segment. While reported diluted EPS saw a slight 3% decline, pro forma diluted EPS, which adjusts for non-recurring items, increased by 9%. The acquisitions led to a notable increase in long-term debt to $244 million, resulting in higher interest expenses. The company also realigned its reporting segments to better reflect its business evolution.
At the time of this filing, HWKN was trading at $161.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $115.35 to $186.15. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.